REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

17/02/2022 16:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220217:nRSQ0497Ca&default-theme=true

RNS Number : 0497C  GlaxoSmithKline PLC  17 February 2022

GlaxoSmithKline plc (the 'Company' and 'GSK')

 

Vesting of Awards under the GSK Deferred Investment Award programme

This notification sets out the vesting details for Persons Discharging
Managerial Responsibilities ('PDMRs') of awards made in 2019 to under the
GlaxoSmithKline Deferred Investment Award programme (the 'Programme'). The
awards, which were conditional on continued employment with the
GlaxoSmithKline group, vested on 14 February 2022.

 

 

Transaction notification

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Ms D Conrad
 b)  Position/status                          Chief People Officer
 c)  Initial notification/                    Initial Notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GlaxoSmithKline plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 25 pence each ('Ordinary Shares')

                                              ISIN: GB0009252882
 b)  Nature of the transaction                Following the vesting on 14 February 2022 of an award made on 3 September 2019
                                              under the GlaxoSmithKline Deferred Investment Award programme, Ms Conrad will
                                              receive a cash payment of £157,905.60 less applicable tax withholding in
                                              respect of 10,050 notional ordinary shares.

 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £15.712               10,050

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2022-02-14
 f)  Place of the transaction                 N/A

 

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Ms S Jackson
 b)  Position/status                          SVP, Global Communication and CEO Office
 c)  Initial notification/                    Initial Notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GlaxoSmithKline plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary shares of 25 pence each ('Ordinary Shares')

                                              ISIN: GB0009252882
 b)  Nature of the transaction                Following the vesting on 14 February 2022 of an award made on 3 September 2019
                                              under the GlaxoSmithKline Deferred Investment Award programme, Ms Jackson will
                                              receive a cash payment of £157,905.60 less applicable tax withholding in
                                              respect of 10,050 notional ordinary shares.

 c)  Price(s) and volume(s)                                         Price(s)              Volume(s)
                                                                    £15.712               10,050

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2022-02-14
 f)  Place of the transaction                 N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEDLFFLLLLBBB